Sign in

or Register now

MyAllergyNetwork.com

See all of our health sites at www.HealthCentral.com
Thursday, July 9, 2009
  • Font size
  • Bookmark
  • Save

Clinical trial: Treating poorly controlled asthma

(National Institutes of Health) UPDATED 2008-09-05
In this Phase II clinical trial, researchers will study the safety and effectiveness of the drug reslizumab in patients who have poorly controlled asthma. This national study is currently recruiting non-smoking asthmatics between the ages of 18 and 75.


  Read full story >
See all Allergy News
  • Font size
  • Bookmark
  • Was this helpful? Yes
  • Save